Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)

Clinical trial NCT00294164 · COMPLETED

Trial details

NCT number: NCT00294164
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)Human Immunodeficiency Virus Infections

Start date: 2001-03-01
Primary completion: 2002-05-01
Enrollment: 245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.